Literature DB >> 31679791

Limited clinical significance of tissue calprotectin levels in bowel mucosa for the prediction of complicated course of the disease in children with ulcerative colitis.

Ondrej Fabian1, Ondrej Hradsky2, Tereza Lerchova2, Filip Mikus3, Josef Zamecnik3, Jiri Bronsky2.   

Abstract

BACKGROUND: Fecal calprotectin (F-CPT) represents one of the most widely used biomarkers for intestinal inflammation. However, the levels may be false negative or false positive in some situations. AIMS: To evaluate the usefulness of immunohistochemical (IHC) detection of tissue calprotectin (T-CPT) in bowel mucosa in children with ulcerative colitis (UC). We focused at correlation of T-CPT with levels of F-CPT and endoscopic and microscopic disease activity at the time of diagnosis and tested whether T-CPT could serve as predictor of complicated course of the disease.
METHODS: Forty-nine children with newly diagnosed UC between 6/2010-1/2018 entered the study. Endoscopic activity was objectified using the Ulcerative Colitis Endoscopic Index of Severity (UCEIS), clinical activity by Pediatric Ulcerative Colitis Activity Index (PUCAI) and microscopic activity by Geboes and Nancy score. The IHC staining for CPT antigen was performed on bioptic samples from 6 bowel segments and the number of CPT + cells were counted per 1HPF. During the minimal follow-up of 12 months we searched for presence of complications. As outcome for Cox regression model we used composite endpoints: A) Acute Severe Colitis, colectomy, anti-TNF treatment; B) systemic corticotherapy; C) systemic 5-aminosalicylic acid therapy.
RESULTS: Neither levels of T-CPT nor values of UCEIS, Geboes or Nancy score predicted the given complications. We found F-CPT levels (HR 2.42 and 2.52) and PUCAI > 40 points (HR 2.98) as predictors of time to endpoints B and C. Good correlation was found between T-CPT levels and Geboes score (k = 0.65) and Nancy score (k = 0.62) and modest with F-CPT (k = 0.44), UCEIS (k = 0.38) and PUCAI (k = 0.42).
CONCLUSIONS: T-CPT correlated well with microscopic scores. F-CPT and PUCAI appear to be better predictors of unfavorable outcome in patients with UC.
Copyright © 2019 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Calprotectin; Immunohistochemistry; Outcome; Ulcerative colitis

Mesh:

Substances:

Year:  2019        PMID: 31679791     DOI: 10.1016/j.prp.2019.152689

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  3 in total

Review 1.  miRNA-Based Potential Biomarkers and New Molecular Insights in Ulcerative Colitis.

Authors:  Jing Zhou; Jialing Liu; Yangyang Gao; Liwei Shen; Sheng Li; Simin Chen
Journal:  Front Pharmacol       Date:  2021-07-09       Impact factor: 5.810

2.  Composite outcomes in observational studies of ulcerative colitis: A systematic review and meta-analysis.

Authors:  Fernando Magro; Catarina Alves; Mafalda Santiago; Paula Ministro; Paula Lago; Luís Correia; Raquel Gonçalves; Diana Carvalho; Francisco Portela; Cláudia Camila Dias; Axel Dignass; Silvio Danese; Laurent Peyrin-Biroulet; Maria Manuela Estevinho; Paula Moreira
Journal:  United European Gastroenterol J       Date:  2021-12-14       Impact factor: 4.623

Review 3.  Histopathological assessment of the microscopic activity in inflammatory bowel diseases: What are we looking for?

Authors:  Ondrej Fabian; Lukas Bajer
Journal:  World J Gastroenterol       Date:  2022-09-28       Impact factor: 5.374

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.